MR编号 | AT/H/0497/001 |
---|
药品名称 | Bendamustine Accord 2.5 mg/ml Powder for concentrate for solution for infusion |
---|
活性成分 | |
---|
剂型 | Powder for concentrate for solution for infusion/injection |
---|
上市许可持有人 | Accord Healthcare B.V
Winthontlaan 200
3526 KV Utrecht
NL |
---|
参考成员国 - 产品名称 | Austria (AT) Bendamustin Accord 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
---|
互认成员国 - 产品名称 | - Latvia (LV)
Bendamustine Accord 2,5 mg/ml pulveris infūziju šķīduma koncentrāta pagatavošanai - Portugal (PT)
- Sweden (SE)
- Czechia (CZ)
Bendamustine Accord 2,5 mg/ml prášek pro koncentrát pro infuzní roztok - Romania (RO)
Bendamustina Accord 2,5 mg/ml pulbere pentru concentrat pentru solutie perfuzabila - Slovenia (SI)
- United Kingdom (GB)
- Cyprus (CY)
BENDAMUSTINE ACCORD - Denmark (DK)
- Germany (DE)
Bendamustine Accord 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung - Iceland (IS)
Bendamustine Accord 2,5 mg/ml Stofn fyrir innrennslisþykkni, lausn - Belgium (BE)
- Ireland (IE)
- France (FR)
- Spain (ES)
- Netherlands (NL)
- Norway (NO)
Bendamustine Accord - United Kingdom (Northern Ireland) (XI)
- Finland (FI)
- Estonia (EE)
Bendamustine Accord - Poland (PL)
Bendamustine Accord - Greece (GR)
BENDAMUSTINE/ACCORD - Hungary (HU)
BENDAMUSTINE ACCORD 2,5 mg/ml por oldatos infúzióhoz való koncentrátumhoz - Italy (IT)
- Malta (MT)
- Lithuania (LT)
Bendamustine Accord 2,5 mg/ml milteliai infuzinio tirpalo koncentratui
|
---|
许可日期 | 2014/07/17 |
---|
最近更新日期 | 2024/12/30 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|